Microbot Medical Inc. (NASDAQ: MBOT) was founded in 2010 and is headquartered in Hingham, Massachusetts, USA, with 8 full-time employees. It is a preclinical medical device company dedicated to research, design and development of minimally invasive surgery spaces Micro-robot assisted medical technology.
Microbot Medical Inc. (MBOT):
Microbot Medical is a medical device company that specializes in the research, design, development and commercialization of transformational microrobot medical technology. Microbot Medical’s vision is to improve the quality of life of millions of patients worldwide by advancing micro-robot technology to perform surgical operations in the human body, and to provide doctors and their patients with less invasive and more precise solutions.
Microbot Medical is developing two product candidates through its ViRob and TipCAT microrobot technologies, including:
- Self-cleaning shunt (Self Cleaning Shunt, SCS TM ) used to treat hydrocephalus and normal pressure hydrocephalus .
- Self-propelled, semi-disposable endoscope for colonoscopy.
Microbot Medical also has an intellectual property portfolio that includes 9 patent series, including 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide.
News from Microbot Medical Inc. (MBOT):
On January 14, 2018, Microbot Medical Inc. announced “very encouraging” research results, proving the potential of its self-cleaning shunt (SCS) products to treat hydrocephalus. As of the close, the stock price has soared +307.92%.
On January 14, 2019, Microbot Medical (MBOT) announced that it has verified the operating efficiency of the company’s self-cleaning shunt (SCS TM ) in a recent independent in vitro laboratory study . The company also shared an image of its SCS TM from laboratory research , which clearly proves that the device prevents shunt blockage, and the stock price soared +307.92%.